97 related articles for article (PubMed ID: 13573078)
1. [Generalized reactions (cyanosis, cardiovascular collapse) caused by sensitization to an aqueous solution of gentian violet and methyl green applied locally].
MICHEL PJ; BUYER R; DELORME
Bull Soc Fr Dermatol Syphiligr; 1958; 65(2):183. PubMed ID: 13573078
[No Abstract] [Full Text] [Related]
2. Accidents of a general nature (cyanosis, cardiovascular collapse) caused by sensitization to aqueous solution of gentian violet & methyl green in local administration.
MICHEL PJ; BUYER R; DELORME
Lyon Med; 1958 Nov; 90(46):798-9. PubMed ID: 13612300
[No Abstract] [Full Text] [Related]
3. Contact-group sensitization to triphenylmethane dyes. Gentian violet, brilliant green, and malachite green.
Bielicky T; Novák M
Arch Dermatol; 1969 Nov; 100(5):540-3. PubMed ID: 5350405
[No Abstract] [Full Text] [Related]
4. Necrotic skin reactions caused by 1 per cent gentian violet and brilliant green.
Björnberg A; Mobacken H
Acta Derm Venereol; 1972; 52(1):55-60. PubMed ID: 4111108
[No Abstract] [Full Text] [Related]
5. [A case of eye injury caused by methyl violet].
SRZEDNICKA-CHRZANOWSKA K
Klin Oczna; 1958; 28(2):165-8. PubMed ID: 13550728
[No Abstract] [Full Text] [Related]
6. Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet.
Wright SC; Maree JE; Sibanyoni M
Phytomedicine; 2009 Mar; 16(2-3):118-24. PubMed ID: 19109001
[TBL] [Abstract][Full Text] [Related]
7. Dermal contact dermatitis; sensitivity to rivanol and gentian violet.
EPSTEIN S
Dermatologica; 1958 Nov; 117(5):287-96. PubMed ID: 13609213
[No Abstract] [Full Text] [Related]
8. Management of the umbilicus with crystal violet solution.
Bale MS
Can Med Assoc J; 1981 Feb; 124(4):372-3. PubMed ID: 7214266
[No Abstract] [Full Text] [Related]
9. Gentian violet keratoconjunctivitis.
Parker WT; Binder PS
Am J Ophthalmol; 1979 Mar; 87(3):340-3. PubMed ID: 434094
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival staining and corneal and conjunctival abrasions caused by 2% aqueous gentian violet solution.
Pessah A; Ofosu JR; Klein BL
Pediatr Emerg Care; 1998 Aug; 14(4):285-6. PubMed ID: 9733255
[No Abstract] [Full Text] [Related]
11. Formation of mucous membrane lesions secondary to prolonged use of one per cent aqueous gentian violet.
SLOTKOWSKI EL
J Pediatr; 1957 Dec; 51(6):652-4. PubMed ID: 13481803
[No Abstract] [Full Text] [Related]
12. [Skin necroses following the use of a 2-per-cent Pyoctanin solution].
Meurer M; Konz B
Hautarzt; 1977 Feb; 28(2):94-5. PubMed ID: 845035
[TBL] [Abstract][Full Text] [Related]
13. Gentian violet in the treatment of oral candidiasis.
Leung AK
Pediatr Infect Dis J; 1988 Apr; 7(4):304-5. PubMed ID: 3368270
[No Abstract] [Full Text] [Related]
14. Targeted therapy of oral hairy leukoplakia with gentian violet.
Bhandarkar SS; MacKelfresh J; Fried L; Arbiser JL
J Am Acad Dermatol; 2008 Apr; 58(4):711-2. PubMed ID: 18342722
[TBL] [Abstract][Full Text] [Related]
15. Keratoconjunctivitis sicca following instillation of gentian violet.
Dhir SP; Sharma SK; Munjal VP; Gupa A
Indian J Ophthalmol; 1982 Jan; 30(1):21-22. PubMed ID: 7141584
[No Abstract] [Full Text] [Related]
16. [Glans penis necrosis secondary to gentian violet treatment].
Zabala Egurrola JA; Pertusa Peña C; Arruza Echevarría A; Llarena Ibarguren R; Arregui-Erbina P; Errasti Olartecoechea G
Arch Esp Urol; 1989 Oct; 42(8):800-2. PubMed ID: 2533476
[TBL] [Abstract][Full Text] [Related]
17. Cleansing solution.
Murphy A
Nurs Times; 1995 Jul 26-Aug 1; 91(30):79. PubMed ID: 7644379
[No Abstract] [Full Text] [Related]
18. [Response to letter to the editor 23(1): 53, 1990: Risk of cancer development in recipients of gentian violet-treated blood. Validity of the interview].
Luquetti AO
Rev Soc Bras Med Trop; 1990; 23(4):237-8. PubMed ID: 2133593
[No Abstract] [Full Text] [Related]
19. [Apropos of the article: anaphylactic shock following the application of Milian's solution].
Bruneau
Phlebologie; 1972; 25(1):11. PubMed ID: 5044953
[No Abstract] [Full Text] [Related]
20. Topical gentian violet in dermatology.
Bunker CB
J Am Acad Dermatol; 2009 Feb; 60(2):347-8. PubMed ID: 19150283
[No Abstract] [Full Text] [Related]
[Next] [New Search]
